Current Protein Identity:Q9BQB4 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2K8P Characterisation of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation Deposited 2008-09-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–213(189 aa) Fragment:UNP residues 25 to 213
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 5.5;308 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR sample composition 310 uM entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 250 uM [U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 200 uM [U-13C; U-15N] entity, 5 % D2O, 95 % H2O, 25 mM sodium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
3SOV The structure of a beta propeller domain in complex with peptide S Deposited 2011-06-30 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Z 115–121(7 aa) Fragment:UNP residues 115-121
Non-standard monomer:Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 FUC alpha-L-fucopyranose × 4 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;0.1M potassium thiocyanate and 30% (w/v) PEG MME 2000, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 1.27 Å R-free 0.180
6L6R Crystal structure of LRP6 E1E2-SOST complex Deposited 2019-10-29 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 24–177(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 MG MAGNESIUM ION × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;301 K;PEG 8000, magnesium acetate, sodium citrate, HEPES
Resolution 3.80 Å R-free 0.256
6L6R Crystal structure of LRP6 E1E2-SOST complex Deposited 2019-10-29 Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 24–177(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;301 K;PEG 8000, magnesium acetate, sodium citrate, HEPES
Resolution 3.80 Å R-free 0.256